Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biologics & biosimilars
3.2.1.2 Rising advancements in bioanalytical technology
3.2.1.3 Increasing prevalence of chronic diseases
3.2.1.4 Increasing research and development in the omics sector
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with these technologies
3.2.2.2 Lack of standardization and validation
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Offering, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Products
5.2.1 Consumables & accessories
5.2.2 Instruments
5.2.3 Reagents & kits
5.3 Service
Chapter 6 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Chromatography
6.3 Mass spectrometry
6.4 ELISA
6.5 Electrophoresis
6.6 Polymerase chain reaction
6.7 Western blot
6.8 Flow cytometry
6.9 Spectrometer
6.10 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Biologics
7.3 Oligonucleotide derived drugs & molecules
7.4 Viral vector
7.5 Cell & gene therapy
7.6 Nanoparticles & polymers
7.7 Disease diagnosis
7.8 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical & biotechnology companies
8.3 Contract research organizations
8.4 Research & academic institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Bio-Rad Laboratories, Inc.
10.2 Bio-Techne Corporation
10.3 Cergentis B.V.
10.4 Charles River Laboratories International, Inc.
10.5 Danaher Corporation
10.6 Halo Labs, Inc
10.7 Intertek Group plc
10.8 Laboratory Corporation of America Holdings
10.9 Shizmandu Corporation
10.10 SOLVIAS AG
